Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. RKLB
2. SPY
3. ACVA
4. RPD
5. CRWV
6. RIOT
7. FERG
8. NVDA
9. HIMS
10. BBIO

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 114.46 -1.89 (1.62%)
Previous Close $116.35    52 Week High $ 
Open $116.97    52 Week Low $ 
Day High $117.36    P/E N/A 
Day Low $113.25    EPS $ 
Volume 210,763